🤖 AI Summary
In psychiatric longitudinal data, symptom heterogeneity and latent-variable confounding frequently invalidate conventional causal effect estimation—particularly because fixed outcome definitions often violate the no-unmeasured-confounding assumption. To address this, we propose a dynamic outcome optimization framework that learns non-negative, clinically interpretable symptom-weighted aggregations to jointly maximize treatment effect persistence and backdoor invariance, accompanied by an empirical test for outcome-level unconfoundedness. Our method integrates time-limited early direct-effect modeling, non-negative weight optimization, and causal robustness regularization to mitigate latent confounding. Evaluated on multi-center cohorts of major depressive disorder and schizophrenia, the framework consistently outperforms state-of-the-art approaches, yielding stable, clinically meaningful composite-outcome causal effects with improved identifiability and interpretability.
📝 Abstract
Causal inference in longitudinal biomedical data remains a central challenge, especially in psychiatry, where symptom heterogeneity and latent confounding frequently undermine classical estimators. Most existing methods for treatment effect estimation presuppose a fixed outcome variable and address confounding through observed covariate adjustment. However, the assumption of unconfoundedness may not hold for a fixed outcome in practice. To address this foundational limitation, we directly optimize the outcome definition to maximize causal identifiability. Our DEBIAS (Durable Effects with Backdoor-Invariant Aggregated Symptoms) algorithm learns non-negative, clinically interpretable weights for outcome aggregation, maximizing durable treatment effects and empirically minimizing both observed and latent confounding by leveraging the time-limited direct effects of prior treatments in psychiatric longitudinal data. The algorithm also furnishes an empirically verifiable test for outcome unconfoundedness. DEBIAS consistently outperforms state-of-the-art methods in recovering causal effects for clinically interpretable composite outcomes across comprehensive experiments in depression and schizophrenia.